Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis.

ABSTRACT: To determine the significance of TAR DNA binding protein 43?kDa (TDP-43) pathology in amyotrophic lateral sclerosis (ALS), we examined the whole brains and spinal cords of 57 patients (35 men; 22 women; mean age 63.3 years; 15 patients with c9orf72-associated ALS [c9ALS]). TDP-43 pathologic burden was determined relative to symptom onset site, disease duration, progression rate, cognitive status, and c9ALS status. There was a trend for greater TDP-43 pathologic burden in cognitively impaired patients (p?=?0.07), though no association with disease duration or progression rate was seen. Shorter disease duration (p?=?0.0016), more severe striatal pathology (p?=?0.0029), and a trend toward greater whole brain TDP-43 pathology (p?=?0.059) were found in c9ALS. Cluster analysis identified "TDP43-limited," "TDP43-moderate," and "TDP43-severe" subgroups. The TDP43-limited group contained more cognitively intact (p?=?0.005) and lower extremity onset site (p?=?0.019) patients, while other subgroups contained more cognitively impaired patients. We conclude that TDP-43 pathologic burden in ALS is associated with cognitive impairment and c9ALS, but not duration of disease or rate of progression. Further, we demonstrate a subgroup of patients with low TDP-43 burden, lower extremity onset, and intact cognition, which requires further investigation.

SUBMITTER: Cykowski MD 

PROVIDER: S-EPMC5901081 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature